Sergio Gil de Dios

Sergio Gil de Dios has a diverse work experience in various roles within the pharmaceutical industry. Starting in 2011, they worked as a Product Manager Trainee at Janssen, Pharmaceutical Companies of Johnson and Johnson, for one year. In 2012, they joined Merck where they served as a Product Manager Trainee for a year, managing multiple products and contributing to team meetings and strategy development. From 2013 to 2017, Sergio worked as a Business Development Contract Manufacturing at ROVI CM. Sergio then joined Consort Medical Plc in 2017 as a Business Development Director, where they worked until 2020 when Recipharm acquired the company. At Recipharm, Sergio took on the role of Director of Business Development, responsible for developing a network of co-development and licensing partners and leading the business case process. In 2022, they briefly served as the Director Strategic Programs at Recipharm.

Sergio Gil de Dios has an Executive MBA in Administration and General Business Management from IESE Business School. Sergio also obtained an MBA from Talento-EPHOS in 2011. Sergio holds a Licenciatura (Bachelor's degree) in Pharmacy from Universidad de Alcalá, completed between 2004 and 2010. Additionally, they attended Utrecht University in 2008-2009. In 2023, Sergio is planning to attend CELforPharma to pursue The Pharmaceutical Out-licensing Course. Sergio has obtained certifications in Excel Skills for Data Analytics and Visualization from Macquarie University in 2022, as well as Excel Skills for Business in 2021.